Overview A Study of A-101 Topical Solution for the Treatment of Common Warts Status: Completed Trial end date: 2019-07-09 Target enrollment: Participant gender: Summary Phase 3 Study of A-101 Topical Solution in Subjects with Common Warts Phase: Phase 3 Details Lead Sponsor: Aclaris Therapeutics, Inc.Treatments: EthanolHydrogen PeroxidePharmaceutical Solutions